.
Friday 7th March 2025
Convene 155 Bishopsgate
.
This website is intended for healthcare professionals
Friday 7th March 2025
Convene 155 Bishopsgate
.
Companies listed have provided sponsorship supporting the conference, with no input or control over the agenda, content creation, or speaker selection, except for their sponsored sessions.
Sessions titles and timings are subject to change and will be finalised closer to the time of the event
This presentation picks up some evolving areas in the world of type 2 diabetes that will impact on Primary Care diabetes management. David will be covering the identification and management of prediabetes, lifestyle pathway to diabetes remission, the expanding role of SGLT2 inhibitors in cardiorenal diseases, and the advent of an oral GLP-1 receptor agonist and a dual GIP/GLP-1 receptor agonist for use in type 2 diabetes.
Gynaecological malignancies account for approximately 11% of newly diagnosed cancers both nationally and globally, cervical, endometrial, and ovarian cancers rank among the most common cancers. Cervical and ovarian cancers, in particular, are notable causes of death worldwide. While most endometrial cancers are diagnosed at early stages, mortality rates have been increasing since 1997. The presentation will look at some of the pathways & innovative treatments in use and discuss some of their impact on the nursing workforce.
Men’s engagement with primary care services is critically in addressing men’s health disparities. Evidence highlights those men, particularly those of working age, use primary care services significantly less frequently than women. This under use has profound implications, contributing to delayed diagnoses or missed opportunities for early intervention in critical conditions such as hypertension, diabetes and mental health disorders. The reluctance to seek care may stem from various factors, including cultural norms around masculinity, work-related time constraints and a lack of awareness or prioritisation of health. Addressing these barriers is essential to improve men’s health outcomes and reduce preventable morbidity and mortality.
This presentation will look at recognition, differential diagnosis and management of six common facial skin conditions. Firstly, we will look at assessment in dermatology, clinical history and examination for recognition and diagnosis of facial skin conditions. Differential diagnosis and facial skin conditions discussed will include acne, rosacea, perioral dermatitis, seborrhoeic dermatitis, contact dermatitis and lupus erythematous. We will look at evidence-based management and holistic patient support, including quality of life issues and when patients should be referred to dermatology. This will be an interactive case-based learning presentation.
Every year, seasonal influenza (‘flu) leads to significant morbidity with some populations (such as older adults, children, pregnant women and people who are clinically at risk) being disproportionately affected. ‘Flu vaccine has been shown to reduce both influenza infection rates and related complications. Whilst uptake increased during the COVID-19 pandemic, this uptake has not been sustained, with uptake in healthcare workers in particular dropping to an all time low. In this session we’ll explore some of the factors contributing to this decline – such as pandemic and vaccine fatigue, a reduced risk perception regarding influenza, resources shift to COVID reducing intention to receive routine vaccines and reduced accessibility to flu vaccines post pandemic. We’ll also look at some of the possible solutions to improve ‘flu vaccination uptake.
This session will empower healthcare providers to integrate combination NRT into their smoking cessation interventions, ultimately improving their quit outcomes. Traditional single-form Nicotine Replacement Therapy (NRT) has helped many smokers quit, but for individuals with high nicotine dependence, these approaches often fall short. Combination NRT has emerged as a game-changing strategy to address these challenges and significantly improve quit rates.
In this talk, attendees will:
• Discover the science behind combination NRT and its ability to provide sustained nicotine levels while addressing acute cravings.
• Learn practical application strategies, including how to assess patient needs, tailor combinations, and manage potential side effects.
This session is sponsored by Chiesi and contains promotional content
Changes in vaccinations and immunisations occur very frequently. In addition, new requirements come in for General Practice and Pharmacists. This session aims to bring the delegates up-to-date with changes in vaccinations and immunisations.